VALSARTAN ARB COVID PLACEBO COVID-19 PRAETORIAN PRAETORIAN-COVID TRIAL STUDY PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN COVID COVID COVID COVID COVID COVID COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID

R.R.J. van Kimmenade

Principal investigator
R.R.J. van Kimmenade, MD, PhD
Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands






D.H.F. Gommans

Coordinating investigator
D.H.F. Gommans, MD, PhD
Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands






Study team
G.W.A. Aarts, MD
Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands

L.S.F. Konijnenberg, MD
Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands

F.B. Mensink, MD
Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands

L.S.F. konijnenberg, G.W.A. Aarts, F.B. Mensink

Steering committee
Prof. N. van Royen, MD, PhD (chair)
Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands

R.R.J. van Kimmenade, MD, PhD
Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands

Prof. M. van den Heuvel, MD, PhD
Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands

Prof. H. van der Hoeven, MD, PhD
Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Prof. A. Verbon, MD, PhD
Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands

Prof. Y.M. Pinto, MD, PhD
Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands

C.P.C. de Jager, MD, PhD
Intensive Care Medicine, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, The Netherlands

Independent expert
G. Geuzebroek, MD, PhD
Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands

VALSARTAN ARB COVID PLACEBO COVID-19 PRAETORIAN PRAETORIAN-COVID TRIAL STUDY PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN COVID COVID COVID COVID COVID COVID COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID

Endpoint adjudication committee
Prof. P.W. de Leeuw, MD, PhD (chair)
Internal Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands

Prof. M.A. van Agtmael, MD, PhD
Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands

P. Bresser, MD, PhD
Pulmonary Diseases, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands

VALSARTAN ARB COVID PLACEBO COVID-19 PRAETORIAN PRAETORIAN-COVID TRIAL STUDY PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN COVID COVID COVID COVID COVID COVID COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID

Data Safety Monitoring Board
Prof. W.H. van Gilst, MD, PhD (chair)
Experimental Cardiology, University Medical Center Groningen, Groningen, The Netherlands

Prof. A. Vonk-Noordergraaf, MD, PhD
Pulmonary Diseases, Amsterdam University Medical Center, Amsterdam, The Netherlands

Prof. J.G.P. Tijssen, MD, PhD
Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands

VALSARTAN ARB COVID PLACEBO COVID-19 PRAETORIAN PRAETORIAN-COVID TRIAL STUDY PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN PRAETORIAN COVID COVID COVID COVID COVID COVID COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID PRAETORIAN-COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID VALSARTAN COVID